MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial

BACKGROUND: Stereotactic body radiotherapy (SBRT) is an established local treatment method for patients with hepatic oligometastasis or oligoprogression. Liver metastases often occur in close proximity to radiosensitive organs at risk (OARs). This limits the possibility to apply sufficiently high do...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoegen, P., Zhang, K. S., Tonndorf-Martini, E., Weykamp, F., Regnery, S., Naumann, P., Lang, K., Ristau, J., Körber, S. A., Dreher, C., Buchele, C., Rippke, C., Renkamp, C. K., Paul, K. M., König, L., Büsch, C., Krisam, J., Sedlaczek, O., Schlemmer, H.-P., Niyazi, M., Corradini, S., Debus, J., Klüter, S., Hörner-Rieber, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958771/
https://www.ncbi.nlm.nih.gov/pubmed/35346270
http://dx.doi.org/10.1186/s13014-022-02033-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958771/
https://www.ncbi.nlm.nih.gov/pubmed/35346270
http://dx.doi.org/10.1186/s13014-022-02033-2

Ejemplares similares